ZA201305497B - Methods and compositions for preventing and treating osteoarthritis - Google Patents

Methods and compositions for preventing and treating osteoarthritis

Info

Publication number
ZA201305497B
ZA201305497B ZA2013/05497A ZA201305497A ZA201305497B ZA 201305497 B ZA201305497 B ZA 201305497B ZA 2013/05497 A ZA2013/05497 A ZA 2013/05497A ZA 201305497 A ZA201305497 A ZA 201305497A ZA 201305497 B ZA201305497 B ZA 201305497B
Authority
ZA
South Africa
Prior art keywords
compositions
preventing
methods
treating osteoarthritis
osteoarthritis
Prior art date
Application number
ZA2013/05497A
Other languages
English (en)
Inventor
Rondo Paul Middleton
Mark Kenneth Waldron
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of ZA201305497B publication Critical patent/ZA201305497B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA2013/05497A 2010-12-21 2013-07-19 Methods and compositions for preventing and treating osteoarthritis ZA201305497B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061459902P 2010-12-21 2010-12-21
PCT/US2011/065173 WO2012087745A1 (en) 2010-12-21 2011-12-15 Methods and compositions for preventing and treating osteoarthritis

Publications (1)

Publication Number Publication Date
ZA201305497B true ZA201305497B (en) 2015-01-28

Family

ID=46314373

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2013/05497A ZA201305497B (en) 2010-12-21 2013-07-19 Methods and compositions for preventing and treating osteoarthritis

Country Status (11)

Country Link
US (1) US20140205569A1 (enExample)
EP (1) EP2654744A4 (enExample)
JP (1) JP2014505679A (enExample)
CN (1) CN103384521A (enExample)
AU (1) AU2011349718B2 (enExample)
BR (1) BR112013018453A2 (enExample)
CA (1) CA2822263A1 (enExample)
MX (1) MX2013007191A (enExample)
RU (1) RU2013133998A (enExample)
WO (1) WO2012087745A1 (enExample)
ZA (1) ZA201305497B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
WO2014022816A2 (en) * 2012-08-03 2014-02-06 Dignity Sciences Limited Pharmaceutical compositions comprising 15-hetre and methods of treating or preventing arthritis using same
WO2015185698A1 (en) 2014-06-04 2015-12-10 Dignity Sciences Limited Pharmaceutical compositions comprising dgla and use of same
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE49783B1 (en) * 1979-05-18 1985-12-11 Efamol Ltd Pharmaceutical and dietary composition comprising epsilon-linolenic acids
GB9403857D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
GB9403855D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
US6765020B2 (en) * 1995-08-07 2004-07-20 Suntory Limited Drugs for prevention and treatment of diseases caused by abnormalities in cartilage tissues
GB9622636D0 (en) * 1996-10-30 1997-01-08 Scotia Holdings Plc Presentation of bioactives
GB9710351D0 (en) * 1997-05-20 1997-07-16 Scotia Holdings Plc Glucosamine fatty acids
JP4343477B2 (ja) * 2000-05-25 2009-10-14 ソシエテ・デ・プロデュイ・ネスレ・エス・アー ペットフード用新規プロバイオチックス
US20020188024A1 (en) * 2000-08-23 2002-12-12 Chilton Floyd H. Fatty acid-containing emulsion with increased bioavailability
US8633247B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
AU2004266601B2 (en) * 2003-08-11 2011-03-24 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for the treatment of canine ostheoarthritis
ES2998457T3 (en) * 2003-11-21 2025-02-20 Nestle Sa Food composition comprising glucosamine
AU2005259386B2 (en) * 2004-07-01 2011-11-03 Société des Produits Nestlé S.A. Canine osteoarthritis diet formulation
EP1852114B1 (en) * 2005-02-14 2019-09-18 Suntory Holdings Limited Composition containing dihomo-y-linolenic acid (dgla) as active ingredient
CN101460185A (zh) * 2006-04-03 2009-06-17 雀巢产品技术援助有限公司 用于促进骨生长和维持骨健康的营养组合物及与其有关的方法

Also Published As

Publication number Publication date
EP2654744A4 (en) 2014-07-02
AU2011349718A1 (en) 2013-07-04
RU2013133998A (ru) 2015-01-27
US20140205569A1 (en) 2014-07-24
EP2654744A1 (en) 2013-10-30
CN103384521A (zh) 2013-11-06
AU2011349718B2 (en) 2017-02-09
BR112013018453A2 (pt) 2018-05-22
JP2014505679A (ja) 2014-03-06
MX2013007191A (es) 2013-07-12
WO2012087745A1 (en) 2012-06-28
CA2822263A1 (en) 2012-06-28

Similar Documents

Publication Publication Date Title
ZA201302625B (en) Methods and compositions for treating hemophilia b
IL227429A0 (en) The components and methods of cancer treatment
IL239918A0 (en) Preparations for the treatment of colitis
IL224390B (en) Compositions and methods for targeted thermal modulation
EP2655334A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
IL218987A0 (en) Methods and compositions for treating cancer
EP2603199A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
EP2523944A4 (en) COMPOUNDS AND COMPOSITIONS FOR IMPROVING COGNITION, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT
EP2603202A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF TAUOPATHIES
IL238416A0 (en) Preparations and methods for the treatment of diseases caused by protein pathology
ZA201303423B (en) Compositions and methods for treating myelofibrosis
SG10201500124VA (en) Methods and Compositions for Treating Cancer
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
ZA201101055B (en) Compositions and methods for treating osteoarthritis
IL215932A0 (en) Compositions and methods for treating burns
ZA201404187B (en) Compositions and methods for treating dental conditions
EP2590674A4 (en) COMPOSITIONS AND METHODS FOR INFLUENZA TREATMENT
IL225483A0 (en) The compositions and methods for the treatment of neoplasia
IL216146A0 (en) Methods and compositions for treating lupus
IL229231A0 (en) Preparations and methods for the treatment of cancer
GB201018650D0 (en) Methods and compositions
ZA201305497B (en) Methods and compositions for preventing and treating osteoarthritis
EP2537031A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
GB2500357B (en) Combination and composition for treating obesity
IL225959A0 (en) Methods and preparations for diagnosis and treatment @ בסרטן